Found 270 matching trials
Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies
PHASE3The main objective of this prospective multisite trial is to study the evol...
Location
Amiens University Hospital
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
PHASE3The main purpose of this study is to compare the disease-free survival betw...
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT
PHASE2Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Location
Hospital Universitario Son Espases
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE2Neoadjuvant chemotherapy plus toripalimab in patients with locoregionally a...
Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3The purpose of this study is to compare induction chemotherapy (gemcitabine...
Location
Sun Yat-sen University Cancer Center
AZA Combined with R-GemOx for Elderly DLBCL Patients
PHASE2This is a prospective, single-arm, multicenter, phase II clinical trial to ...
Location
Daping Hospital, Third Military Medical University (Army Medical University)
Electro-Acupuncture in Lung cancER : EALER Study
NAThis multicentre, randomized controlled trial evaluates the effect and safe...
Location
Guangdong Provincial Hospital of Chinese Medicine
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
PHASE1This is a single-center, open-label, phase I study designed to determine th...
Location
Froedtert & the Medical College of Wisconsin
Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse
PHASE1The purpose of this study is to determine the recommended dose of CMC544 ad...
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL
PHASE3This is a randomized, open-label, prospective, multicenter phase III superi...
Location
Fudan University Shanghai Cancer Center,